Megumi Yanokura
Overview
Explore the profile of Megumi Yanokura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
912
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yanokura M, Banno K, Aoki D
Int J Oncol
. 2020 Dec;
57(5):1145-1156.
PMID: 33300049
Aberrant DNA methylation is widely observed in various types of cancer, and expression of microRNAs (miRNAs/miRs) is suppressed by DNA methylation. The present study explored tumor suppressor miRNAs downregulated by...
2.
Umene K, Banno K, Kisu I, Yanokura M, Nogami Y, Tsuji K, et al.
Biomed Rep
. 2019 Dec;
11(6):274.
PMID: 31798873
[This corrects the article DOI: 10.3892/br.2013.91.].
3.
Takeda T, Banno K, Kobayashi Y, Adachi M, Yanokura M, Tominaga E, et al.
Oncol Rep
. 2019 Oct;
42(6):2303-2308.
PMID: 31638232
Endometrial polyps are common, yet the molecular mechanisms underlying their formation and progression remain unclear. We examined gene mutations possibly related to the pathogenesis of endometrial polyps, as well as...
4.
Matoba Y, Kisu I, Sera A, Yanokura M, Banno K, Aoki D
Biomed Rep
. 2019 Jan;
10(2):79-86.
PMID: 30675350
Though assisted reproduction technology has been developed, a treatment for absolute uterine factor infertility (AUFI), such as defects in the uterus, has not yet been established. Regenerative medicine has been...
5.
Synchronous endometrial and ovarian cancer in Lynch syndrome with a germline mutation: A case report
Takeda T, Banno K, Yanokura M, Anko M, Kobayashi A, Sera A, et al.
Mol Clin Oncol
. 2018 Nov;
9(5):479-484.
PMID: 30402230
Synchronous endometrial and ovarian cancer (SEOC) is a rare entity among gynecological cancers, which exhibits endometrioid histology in its early stages and generally has a good prognosis. However, diagnosis is...
6.
Takeda T, Tsuji K, Banno K, Yanokura M, Kobayashi Y, Tominaga E, et al.
J Gynecol Oncol
. 2018 Feb;
29(3):e29.
PMID: 29400022
Objective: Lynch syndrome is a cancer predisposition syndrome caused by germline mutation of DNA mismatch repair (MMR) genes. Lynch syndrome only causes about 0.4% of cases of ovarian cancer, which...
7.
Yanokura M, Banno K, Kobayashi Y, Nomura H, Hayashi S, Tominaga E, et al.
Mol Clin Oncol
. 2017 Nov;
7(5):733-737.
PMID: 29181164
Selective aberrant genetic effects that do not depend on abnormal DNA sequences are referred to as epigenetic abnormalities and are involved in carcinogenesis. In uterine cancer, various genes involved in...
8.
Okawa R, Banno K, Iida M, Yanokura M, Takeda T, Iijima M, et al.
Oncol Lett
. 2017 Nov;
14(5):5107-5113.
PMID: 29113150
Epigenetic regulatory mechanisms are a current focus in studies investigating cancer. Chromatin remodeling alters chromatin structure and regulates gene expression, and aberrant chromatin remodeling is involved in carcinogenesis. AT-rich interactive...
9.
Kunitomi H, Banno K, Yanokura M, Takeda T, Iijima M, Nakamura K, et al.
Oncol Lett
. 2017 Sep;
14(3):3297-3301.
PMID: 28927079
The increasing incidence of obesity and diabetes due to changes in diet, earlier menarche, delayed menopause, late marriage, and declining birth rate have resulted in an increase in the number...
10.
Iijima M, Banno K, Okawa R, Yanokura M, Iida M, Takeda T, et al.
Oncol Lett
. 2017 Apr;
13(3):1063-1070.
PMID: 28454214
Cancer typically develops due to genetic abnormalities, but a single gene abnormality cannot completely account for the onset of cancer. The Cancer Genome Atlas (CGA) project was conducted for the...